arrow
I

Ishan Roy

Shirley Ryan AbilityLab
H指数:12
被引数:703

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of Bispecific Antibodies After CAR T-Cell Failure for Large B-cell Lymphoma- Results from the ABC Consortium

大B细胞淋巴瘤在CAR T细胞治疗失败后使用双特异性抗体的疗效——ABC Consortium研究的结果

2025-10-240
OAAI
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and Efficacy

纳武利尤单抗联合R-CHOP方案治疗初治弥漫性大B细胞淋巴瘤:安全性与有效性的评估

2025-07-280
OAAI
Natural language processing algorithms identify wild-type isocitrate dehydrogenase gliomas in electronic health records

自然语言处理算法在电子健康记录中识别野生型异柠檬酸脱氢酶胶质瘤

2025-01-010
OAAI
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
2024-05-285
OAAI
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
2024-05-166
OAAI
Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL

所有car-t患者和侵袭性b-nhl的car-t后失败的围术期实践模式和生存预测指标

2023-06-1427
OAAI
Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation
2017-03-2179
OAAI